News

Poor thyroid status raises mortality in patients with heart failure


 

References

Thyroid dysfunction was associated with an increased risk of mortality in patients with heart failure due to idiopathic dilated cardiomyopathy (IDCM), according to research reported in the Journal of Clinical Endocrinology and Metabolism.

Lead author Wenyao Wang of the Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, and associates gathered data from 458 consecutive patients with IDCM who were admitted to the National Center of Cardiovascular diseases in Beijing, and then evaluated their risk of mortality based on levels of free T3 and TSH and the whole thyroid function profile.

Hypothyroidism was the strongest predictor of mortality (hazard ratio, 4.189; 95% confidence interval, 2.118-8.283), followed by low-T3 syndrome (HR, 3.147; 95% CI, 1.558-6.355) and subclinical hypothyroidism (HR, 2.869; 95% CI, 1.817-4.532); subclinical hyperthyroidism did not have a significant impact on mortality. The most common forms of thyroid dysfunction were subclinical hypothyroidism (n = 41, 9%), followed by subclinical hyperthyroidism (n = 35, 7%), low-T3 syndrome (n = 17, 4%), and overt hypothyroidism (n = 12, 3%).

“Monitoring thyroid function is necessary for patients with IDCM, and further study is warranted to investigate whether reversing low thyroid function can benefit these patients,” the investigators noted.

Read the full article here: (J. Clin. Endocrinol. Metab. 2015 [doi:10.1210/jc.2014-4159]).

The investigators reported that they had no financial disclosures to make.

mbock@frontlinemedcom.com

Recommended Reading

Nonfunctioning pituitary adenoma linked to higher mortality in women
MDedge Endocrinology
Copeptin levels predicted diabetes insipidus after pituitary surgery
MDedge Endocrinology
AACE: Free testosterone, prolactin levels signal MRI need in men with secondary hypogonadism
MDedge Endocrinology
AACE: Artificial sweeteners tentatively linked to Hashimoto’s thyroiditis
MDedge Endocrinology
Subclinical hyperthyroidism linked to higher fracture risk
MDedge Endocrinology
Thyroid surgery on the rise
MDedge Endocrinology
AACE: Endocrine treatment of childhood cancer survivors needs improvement
MDedge Endocrinology
AACE: How to safely skip radioactive iodine for low-grade thyroid cancer
MDedge Endocrinology
ASA: Mutation testing aids decision making in thyroid cancer
MDedge Endocrinology
Thyroid cancer outcomes worse for black and Hispanic young adults
MDedge Endocrinology